These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39029338)

  • 1. Synthesis and evaluation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate analogs as competitive partial agonists of butyrophilin 3A1.
    Singh R; Rani S; Jin Y; Hsiao CC; Wiemer AJ
    Eur J Med Chem; 2024 Oct; 276():116673. PubMed ID: 39029338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1.
    Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S
    Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
    Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
    Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
    Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
    Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region.
    Nguyen K; Li J; Puthenveetil R; Lin X; Poe MM; Hsiao CC; Vinogradova O; Wiemer AJ
    FASEB J; 2017 Nov; 31(11):4697-4706. PubMed ID: 28705810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationships of Butyrophilin 3 Ligands.
    Wiemer AJ
    ChemMedChem; 2020 Jun; 15(12):1030-1039. PubMed ID: 32453919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.
    Shippy RR; Lin X; Agabiti SS; Li J; Zangari BM; Foust BJ; Poe MM; Hsiao CC; Vinogradova O; Wiemer DF; Wiemer AJ
    J Med Chem; 2017 Mar; 60(6):2373-2382. PubMed ID: 28218845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold.
    Harmon NM; Poe MM; Huang X; Singh R; Foust BJ; Hsiao CC; Wiemer DF; Wiemer AJ
    ACS Med Chem Lett; 2022 Feb; 13(2):164-170. PubMed ID: 35178171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.
    Kilcollins AM; Li J; Hsiao CH; Wiemer AJ
    J Immunol; 2016 Jul; 197(2):419-28. PubMed ID: 27271567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.
    Hsiao CH; Lin X; Barney RJ; Shippy RR; Li J; Vinogradova O; Wiemer DF; Wiemer AJ
    Chem Biol; 2014 Aug; 21(8):945-54. PubMed ID: 25065532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production.
    Alice AF; Kramer G; Bambina S; Bahjat KS; Gough MJ; Crittenden MR
    Sci Rep; 2021 Aug; 11(1):16347. PubMed ID: 34381163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.
    Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T
    Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the Ligand-Binding Pocket of BTN3A1.
    Poe MM; Agabiti SS; Liu C; Li V; Teske KA; Hsiao CC; Wiemer AJ
    J Med Chem; 2019 Jul; 62(14):6814-6823. PubMed ID: 31268699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
    Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
    Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.
    Nerdal PT; Peters C; Oberg HH; Zlatev H; Lettau M; Quabius ES; Sousa S; Gonnermann D; Auriola S; Olive D; Määttä J; Janssen O; Kabelitz D
    J Immunol; 2016 Oct; 197(8):3059-3068. PubMed ID: 27619996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
    Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
    J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.